Cell Line Lysates
Abcam Human GNB1 knockout HCT116 cell lysate.
Human GNB1 knockout HCT116 cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human BLVRA (BVR) knockout HEK-293T cell lysate.
Human BLVRA (BVR) knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human WIBG (PYM) knockout HEK-293T cell lysate.
Human WIBG (PYM) knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human HOXA9 knockout HEK-293 cell lysate.
Human HOXA9 knockout HEK-293 cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human BRAP knockout HEK-293T cell lysate.
Human BRAP knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Eurofins Discoverx InCELL Hunter™ Human MEK1 Kinase Target Engagement Cell-Based Assay Kit (A549)
The InCELL Hunter™ Human MEK1 Stable Cell Line Target Engagement Assay (A549) contains a stable clonal cell line used to measure target engagement via compound-induced stabilization of MEK1 target protein. This is a complete kit that includes the cell vials and all required reagents needed for cell culture and running the assay.
ABclonal Technology Bcl10 Rabbit pAb
This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants.
Cayman Chemical BasInolIde 2.5mg
A cyclodepsipeptide insecticide; synthesized by B. bassiana and V. lecanii; induces atony in B. mori when given orally at concentrations as low as 4 ppm; inhibits the muscarinic, but not nicotinic, receptor-induced contractions in response to acetylcholine in smooth muscle
Abcam Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell lysate.
Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical AvermectIn B1b 2.5mg
A minor component of avermectin broth, used broadly against nematodes, ticks, flies, and ants
Cayman Chemical ThIelavIn B 2.5mg
A fungal metabolite that inhibits cyclooxygenase, blocking both the conversion of AA to PGH2 and the conversion of PGH2 to PGE2 (IC50s = 40 and 9 µM, respectively); also inhibits the reverse transcriptase of avian myeloblastosis virus, bacterial transglycosylases, and telomerase activity
Macherey-Nagel MACHEREY-NAGEL Lysis Buffer LYS-EF, Endotoxin-Free Plasmid Isolation, Compatible With NucleoBond Xtra Kits, 1000 mL
The MACHEREY-NAGEL Lysis Buffer LYS-EF is designed for effective cell lysis in endotoxin-free plasmid DNA isolation, essential for high-quality DNA suitable for sensitive molecular biology applications. This buffer is particularly compatible with NucleoBond Xtra Midi and Maxi EF kits, setting it apart for its specialized formulation that meets rigorous research standards.
Abcam Human PPP2R5C knockout HEK-293T cell lysate.
Human PPP2R5C knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human MKNK1 (MNK1) knockout HeLa cell lysate.
Human MKNK1 (MNK1) knockout HeLa cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human G6PC3 knockout HEK-293T cell lysate.
Human G6PC3 knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement